Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Lung Neoplasms 10 Stomach Neoplasms 9 Neoplasm Metastasis 8 Breast Neoplasms 8 Esophageal Neoplasms 7 Colorectal Neoplasms 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Leukemia, Myeloid, Acute 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Nasopharyngeal Carcinoma 4 Esophageal Squamous Cell Carcinoma 4 Adenocarcinoma Of Esophagus 4 Uterine Cervical Neoplasms 3 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Mouth Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Glioma 2 Endometrial Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Ovarian Epithelial 2 Anus Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2

Interventions

Doxorubicin 14 pembrolizumab 11 Specimen Handling 11 Magnetic Resonance Spectroscopy 10 Biopsy 9 Cyclophosphamide 8 X-Rays 7 Radiotherapy 7 Nivolumab 7 Ifosfamide 7 Phantoms, Imaging 6 Gemcitabine 6 liposomal doxorubicin 5 Temozolomide 5 Radiation 5 tazemetostat 4 palbociclib 4 Trabectedin 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 Ipilimumab 4 pazopanib 3 larotrectinib 3 fludarabine 3 cabozantinib 3 atezolizumab 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Proton Therapy 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Drug Therapy × 90 days × Clear all

NCT04307277 2026-04-14

CHIC-STS01

Institut Claudius Regaud

Phase 3 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡